Abstract LB-062: Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles

MLA

Hunt Hedi, et al. “Abstract LB-062: Targeting of P32 in Peritoneal Carcinomatosis with Intraperitoneal LinTT1 Peptide-Guided pro-Apoptotic Nanoparticles.” Cancer Research, vol. 77, July 2017, p. LB-062. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3e165305c66fb3f75a604ddf028ea8a4&authtype=sso&custid=ns315887.

APA

Hunt Hedi, Shweta Sharma, Kazuki N. Sugahara, Tambet Teesalu, Erkki Ruoslahti, Allan Tobi, & Lorena Simón-Gracia. (2017). Abstract LB-062: Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. Cancer Research, 77, LB-062.

Chicago

Hunt Hedi, Shweta Sharma, Kazuki N. Sugahara, Tambet Teesalu, Erkki Ruoslahti, Allan Tobi, and Lorena Simón-Gracia. 2017. “Abstract LB-062: Targeting of P32 in Peritoneal Carcinomatosis with Intraperitoneal LinTT1 Peptide-Guided pro-Apoptotic Nanoparticles.” Cancer Research 77 (July): LB-062. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3e165305c66fb3f75a604ddf028ea8a4&authtype=sso&custid=ns315887.